ArticlePlant physiology2026
Chassis selection and metabolic fine-tuning enable efficient in planta betalain production.
Article in Plant physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Better synthetic biology outcomes through balanced push-pull engineering.Plant physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Synthetic biology enables efficient production of valuable compounds in biological systems, including plants that capture atmospheric CO2 to synthesize and accumulate abundant and diverse specialized metabolites. Most plant synthetic biology studies to produce specialized metabolites have primarily used Nicotiana benthamiana as an underpinning metabolic chassis, due to its rapid agroinfiltration method, leaving much of the metabolic potential of other plant species underexplored. Here we engineered 3 distinct plant chassis-Arabidopsis, tobacco and soybean-by stably introducing an optimized betalain biosynthetic pathway and analyzed their metabolic impacts. Betalains are tyrosine-derived pigments, which are used as natural red and yellow food dyes with rapidly growing demand due to a recent regulatory shift. We fine-tuned metabolic balances by redesigning the RUBY betalain construct (RUBYv2), adding an extra DODA enzyme ("pull") and modulating tyrosine precursor supply ("push") using 2 different promoters. The "push-and-pull (push + pull)" lines produced higher betalain levels than the "pull" lines in all 3 species, even exceeding those of beet roots. While Arabidopsis and tobacco "push + pull" lines driven by a strong promoter showed dwarfism, corresponding soybean lines did not show severe growth defects, suggesting greater tolerance of soybean to the engineered pathway. This study demonstrates that careful plant chassis selection, coupled with precise control of pathway expression, is essential for maximizing the yield of target specialized metabolites, such as betalain pigments, without impairing overall plant growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.